Hodgkin's Disease News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL? Test for ... - GlobeNewswire (press release)



Streetwise Reports
 
3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL? Test for ... 
GlobeNewswire (press release)
TORONTO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce that a preliminary third-party analysis of the trial data for Telo-HLTM, 3DS' test in development for ...
Can a Simple Test Really Predict Whether a Cancer Treatment Will Succeed? Streetwise Reports

all 3 news articles » 


Global Hodgkin's Lymphoma Market Spotlight 2017-2027 - ResearchAndMarkets.com - Business Wire (press release)



Global Hodgkin's Lymphoma Market Spotlight 2017-2027 - ResearchAndMarkets.com 
Business Wire (press release)
The report estimates that in 2016, there were 70,700 incident cases of Hodgkin's lymphoma worldwide, and expects that number to increase to 77,400 incident cases by 2025. Incidence rates are slightly higher in males compared to females, and are highest ...

and more » 


Polygenic Risk Scores Show Utility for Stratifying Disease Risk - Genetic Engineering & Biotechnology News



Genetic Engineering & Biotechnology News
 
Polygenic Risk Scores Show Utility for Stratifying Disease Risk 
Genetic Engineering & Biotechnology News
Researchers calculated PRS for 12 cancer traits, including breast, prostate, skin, basal cell, bladder, non-Hodgkin's lymphoma, colon, squamous cell, kidney, lung, thyroid, and brain and nervous system carcinomas. Phenome-wide associations were found ...

 


Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma - Pharmacy Today, American Pharmacists Association, pharmacist.com



Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma 
Pharmacy Today, American Pharmacists Association, pharmacist.com
Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma. Share This Page. January 26, 2018. Because up to 30% of advanced Hodgkin's lymphoma patients succumb to refractory disease or relapse after first-line treatment with ...

 


Autoimmune Encephalitis Pathophysiology - News-Medical.net



News-Medical.net
 
Autoimmune Encephalitis Pathophysiology 
News-Medical.net
Others include anti-Yo, anti-Ri, amphiphysin, Ma2, and Tr. Associated tumors may include small cell carcinoma of the lung, Hodgkin's lymphoma, thymoma, germ cell testicular tumors, neuroblastomas, breast cancer and ovarian teratoma. Within the brain ...

and more » 


Look out for redshirt freshman OL, cancer survivor Brodarious Hamm in Auburn football spring practice - SECcountry.com



SECcountry.com
 
Look out for redshirt freshman OL, cancer survivor Brodarious Hamm in Auburn football spring practice 
SECcountry.com
One month after signing with the Tigers, he was diagnosed with Hodgkin's lymphoma. Hamm arrived at Auburn and enrolled in classes, but he took that first year away from football to fight the disease. MORE: Auburn football has important visitor for big ...

and more » 


DAAs Well Tolerated with Chemotherapy for Comorbid HCV, Non-Hodgkin's Lymphoma - MD Magazine



MD Magazine
 
DAAs Well Tolerated with Chemotherapy for Comorbid HCV, Non-Hodgkin's Lymphoma 
MD Magazine
The investigators recruited 20 consecutive HCV-positive genotype 1b-infected patients affected with diffuse large B-cell lymphoma (DLBCL; 13 male, 7 female) referred to 1 of 3 hepatology clinics for DAA treatment, from hematological treatment centers ...

 


Hodgkin's lymphoma (HL) Market Epidemiology Key Strengths, 7MM Coverage, Cases, Assessments and Forecast 2027 - The Financial



Hodgkin's lymphoma (HL) Market Epidemiology Key Strengths, 7MM Coverage, Cases, Assessments and Forecast 2027 
The Financial
Hodgkin's lymphoma (HL) Market ? Epidemiology Forecast, 2027 comprises of extensive primary research along with the detailed analysis by qualitative as well as quantitative aspects of Hodgkin's lymphoma (HL) Market epidemiology providing the historical ...

and more » 


Non-Hodgkin's Lymphoma (NHL) Market Epidemiology ... - The Financial



Non-Hodgkin's Lymphoma (NHL) Market Epidemiology ... 
The Financial
Non-Hodgkin's Lymphoma (NHL) Market ? Epidemiology Forecast, 2027 comprises of extensive primary research along with the detailed analysis by qualitative as well as quantitative aspects of Non-Hodgkin's Lymphoma (NHL) Market epidemiology providing the ...

and more » 


The partnership ushered in a new era of oncological care - Philadelphia Business Journal



Philadelphia Business Journal
 
The partnership ushered in a new era of oncological care 
Philadelphia Business Journal
Novartis spokesman Eric Althoff said as the collaboration progresses the company is studying new indications for Kymriah including its use as a potential treatment to diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma among ...